Does gonadotropin-releasing-hormone agonist therapy for prostate cancer increase the risk of fracture? Commentary

Andrew J. Armstrong, Mario Eisenberger

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)246-247
Number of pages2
JournalNature Clinical Practice Urology
Volume3
Issue number5
DOIs
StatePublished - May 1 2006

Keywords

  • Bone mineral density
  • Fracture
  • Gonadotropin-releasing-hormone agonist
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this